Advancing performance measurement in oncology: Quality oncology practice initiative participation and quality outcomes

Journal of Oncology Practice

Volumn 7, Issue 3 SUPPL., 2011, Pages

  Campion, Francis X ^a,b,c,d   Larson, Leanne R ^a,b,c,d   Kadlubek, Pamela J ^a,b,c,d   Earle, Craig C ^a,b,c,d   Neuss, Michael N ^a,b,c,d  

^a Outcome Sciences Inc   (United States)

^b AMERICAN SOCIETY OF CLINICAL ONCOLOGY   (United States)

^c INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^d Oncology Hematology Care   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CENTER; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CLINICAL PRACTICE; FEMALE; HEALTH CARE COST; HEALTH CARE QUALITY; HOSPICE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONCOLOGY; PERFORMANCE MEASUREMENT SYSTEM; REVIEW; TOTAL QUALITY MANAGEMENT;

EID: 80052759443     PISSN: 15547477     EISSN: 1935469X     Source Type: Journal    
DOI: 10.1200/JOP.2011.000313     Document Type: Review

References (28)

1. Committee on Quality of Health Care in America, Institute of Medicine: Crossing the Quality Chasm: A New Health System for the 21st Century. National Academies Press, Washington, DC, 2001
2. Hewitt M, Simone JV (eds): Ensuring Quality Cancer Care. National Academies Press, Washington, DC, 1999
3. National Committee for Quality Assurance: State of health care quality. http://www.ncqa.org/tabid/836/Default.aspx
4. Berwick DM: Medicare head Donald M. Berwick, MD, takes on mission of health system reform: Interview by Mike Mitka. JAMA 304:2227-2228, 2010
5. Berwick DM, Nolan TW, Whittington J: The triple aim: Care, health, and cost. Health Aff (Millwood) 27:759-769, 2008 (Pubitemid 351770245)
6. America's Health Insurance Plans: Innovations in recognizing and rewarding quality. http://www.ahip.org/content/default.aspx?docid=26393
7. Reeves MJ, Parker C, Fonarow GC, et al: Development of stroke performance measures: definitions, methods, and current measures. Stroke 41:1573-1578, 2010
8. Medicare and Medicaid Programs Electronic Health Record Incentive Program: Final Rule. The Federal Register 42 CFR Parts 412, 413, 422, et al, 2010
9. American Association of Neurological Surgeons: What services does Neuro-Point Alliance offer? http://www.aans.org/en/NeuroPoint/FAQ-Answers6.aspx
10. American College of Rheumatology: Rheumatology clinical registry: Data-driven, optimal care. http://www.rheumatology.org/practice/clinical/rcr.asp
11. Dreyer NA, Tunis SR, Berer M, et al: Why observational studies should be among the tools used in comparative effectiveness research. Health Aff 29:1818-1825, 2010
12. Neuss MN, Desch CE, McNiff KK, et al: A process for measuring the quality of cancer care: The Quality Oncology Practice Initiative. J Clin Oncol 23:6233-6239, 2005
13. Blayney DW, Stella PJ, Ruane T, et al: Partnering with payers for success: Quality Oncology Practice Initiative, Blue Cross Blue Shield of Michigan, and the Michigan Oncology Quality Consortium. J Oncol Pract 5:281-284, 2009
14. Griffin JP, Nelson JE, Koch KA, et al: End-of-life care in patients with lung cancer. Chest 123:312S-331S, 2003. (Pubitemid 36135724)
15. Wright AA, Zhang B, Ray A, et al: Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment. JAMA 300:1665-1673, 2008
16. Von Gruenigen VE, Hutchins JR, Reidy AM, et al: Gynecologic oncology patients' satisfaction and symptom severity during palliative chemotherapy. Health Qual Life Outcomes 4:84, 2006
17. Herrinton LJ, Neslund-Dudas C, Rolnick SJ, et al: Complications at the end of life in ovarian cancer. J Pain Symptom Manage 34:237-243, 2007 (Pubitemid 47371073)
18. Lewin SN, Buttin BM, Powell MA, et al: Resource utilization for ovarian cancer patients at the end of life: How much is too much? Gynecol Oncol 99:261-266, 2005 (Pubitemid 41502829)
19. Von Gruenigen V, Daly B, Gibbons H, et al: Indicators of survival duration in ovarian cancer and implications for aggressiveness of care. Cancer 112:2221-2227, 2008 (Pubitemid 351628632)
20. Kao S, Shafiq J, Vardy J, et al: Use of chemotherapy at end of life in oncology patients. Ann Oncol 20:1555-1559, 2009
21. Court A: The cost of dying: End-of-life care. http://www.cbsnews.com/ stories/2010/08/05/60minutes/main6747002.shtml
22. Earle CC, Landrum MB, Souza JM, et al: Aggressiveness of cancer care near the end of life: Is it a quality-of-care issue? J Clin Oncol 26: 3860-3866, 2008
23. Temel JS, Greer JA, Muzikansky A, et al: Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 363:733-742, 2010
24. Campbell DE, Lynn J, Louis TA, et al: Medicare program expenditures associated with hospice use. Ann Intern Med 140:269-277, 2004 (Pubitemid 38200534)
25. Christakis NA, Escarce JJ: Survival of Medicare patients after enrollment in hospice programs. N Engl J Med 335:172-178, 1996 (Pubitemid 26249455)
26. Zhang B, Wright AA, Huskamp HA, et al: Health care costs in the last week of life: Associations with end-of-life conversations. Arch Intern Med 169:480-488, 2009
27. Seow H, Snyder CF, Mularski RA, et al: A framework for assessing quality indicators for cancer care at the end of life. J Pain Symptom Manage 38:903-912, 2009
28. Woodward M: Epidemiology: Study Design and Data Analysis (ed 2). Chapman & Hall/CRC, London, England, 2004